Author

Ta‐Chen Wu

Observed name: Ta-Chen Wu

Institution: United States Food and Drug Administration

Observed institutions: United States Food and Drug Administration, University of Illinois Chicago

OpenAlex ID: A5111366068

Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

2012 · Ping Zhao, Manuela de L. T. Vieira, et al. · The Journal of Clinical Pharmacology · 98

Correlation of Plasma Clearance of 54 Extensively Metabolized Drugs Between Humans and Rats: Mean Allometric Coefficient of 0.66

1998 · Win L. Chiou, Gabriel Robbie, et al. · Pharmaceutical Research · 61

Poor and Unusually Prolonged Oral Absorption of Amphotericin B in Rats

1999 · Gabriel Robbie, Ta-Chen Wu, et al. · Pharmaceutical Research · 20

Unexpected Lack of Effect of the Rifampin-Induced P-Glycoprotein on the Oral Bioavailability of its Substrate, Talinolol, in Humans: Implication in Phenotyping

2002 · Win L. Chiou, Chien Ma, et al. · Journal of Pharmaceutical Sciences · 5

Works count: 4

Citation count: 184

H-index: 4

I10-index: 3